C Maugeais
Overview
Explore the profile of C Maugeais including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu J, Cleary Y, Maugeais C, Kiu Weber C, Mazer N
CPT Pharmacometrics Syst Pharmacol
. 2015 Sep;
4(8):465-73.
PMID: 26380155
RG7232 is a potent inhibitor of cholesteryl-ester transfer protein (CETP). Daily oral administration of RG7232 produces a dose- and time-dependent increase in high-density lipoprotein-cholesterol (HDL-C) and apolipoproteinA-I (ApoA-I) levels and...
2.
Zanotti I, Maugeais C, Pedrelli M, Gomaraschi M, Salgam P, Calabresi L, et al.
Br J Pharmacol
. 2011 Apr;
164(6):1642-51.
PMID: 21449977
Background And Purpose: Ro 11-1464 is a thienotriazolodiazepine previously described to selectively stimulate apolipoprotein A-I (apoA-I) production and mRNA level in human liver cells. Here, we studied its effects upon...
3.
Ouguerram K, Maugeais C, Gardette J, Magot T, Krempf M
Br J Nutr
. 2006 Jul;
96(1):100-6.
PMID: 16869997
The effect of long-chain n-3 PUFA on the metabolism of apoB100-containing lipoprotein in diabetic subjects is not fully understood. The objective of the present study was to determine the effect...
4.
Ouguerram K, Krempf M, Maugeais C, Maugere P, Darmaun D, Magot T
Metabolism
. 2002 Jan;
51(1):5-11.
PMID: 11782865
A method to study reverse cholesterol transport in humans was developed using stable isotopes and kinetic analysis. Three normolipidemic subjects received simultaneous intravenous infusions of deuterated leucine and (13)C-acetate for...
5.
Frenais R, Ouguerram K, Maugeais C, Mahot P, Charbonnel B, Magot T, et al.
Atherosclerosis
. 2001 Jun;
157(1):131-5.
PMID: 11427212
The effect of a dietary fish oil supplementation on metabolism of HDL was studied in type II diabetes mellitus. Endogenous labeling of HDL-apo AI was performed using a 14 h...
6.
Frenais R, Maugeais C, Ouguerram K, Zair Y, Bard J, Charbonnel B, et al.
Metabolism
. 2001 Jun;
50(6):635-9.
PMID: 11398137
In patients with heterozygous familial hypercholesterolemia (FH), both synthetic and clearance rates of high-density lipoproteins (HDL) are increased compared with control subjects. According to in vitro data on hepatocytes, the...
7.
Frenais R, Nazih H, Ouguerram K, Maugeais C, Zair Y, Bard J, et al.
J Clin Endocrinol Metab
. 2001 May;
86(5):1962-7.
PMID: 11344192
The aim of this study was to delineate the role of lipoprotein lipase (LPL) activity in the kinetic alterations of high density lipoprotein (HDL) metabolism in patients with type II...
8.
Maugeais C, Ouguerram K, Frenais R, Maugere P, Charbonnel B, Magot T, et al.
J Clin Endocrinol Metab
. 2001 Apr;
86(4):1679-86.
PMID: 11297603
The acute reduction of low-density lipoprotein (LDL) cholesterol obtained by LDL-apheresis allows the role of the high level of circulating LDL on lipoprotein metabolism in heterozygous familial hypercholesterolemia (heterozygous FH)...
9.
Kawashiri M, Maugeais C, Rader D
Curr Atheroscler Rep
. 2000 Dec;
2(5):363-72.
PMID: 11122767
New therapeutic approaches to the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD) are needed. Plasma levels of high-density lipoprotein (HDL) cholesterol are inversely associated with risk of ASCVD. Genes...
10.
Tangirala R, Pratico D, FitzGerald G, Chun S, Tsukamoto K, Maugeais C, et al.
J Biol Chem
. 2000 Oct;
276(1):261-6.
PMID: 11024044
Apolipoprotein E is a multifunctional protein synthesized by hepatocytes and macrophages. Plasma apoE is largely liver-derived and known to regulate lipoprotein metabolism. Macrophage-derived apoE has been shown to reduce the...